StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note issued to investors on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
Athersys has a fifty-two week low of $0.01 and a fifty-two week high of $1.99. The company has a market cap of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90.
Athersys Company Profile
Further Reading
- Five stocks we like better than Athersys
- Business Services Stocks Investing
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- What is a Low P/E Ratio and What Does it Tell Investors?
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
